These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38826105)

  • 1. Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes.
    He Y; Kunutsor SK; Kingsnorth AP; Gillies C; Choudhary P; Khunti K; Zaccardi F
    Diabetes Obes Metab; 2024 Aug; 26(8):3361-3370. PubMed ID: 38826105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
    Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
    Diabetes Obes Metab; 2016 Sep; 18(9):907-15. PubMed ID: 27161418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
    Kern W; Holstein A; Moenninghoff C; Kienhöfer J; Riedl M; Kulzer B
    Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
    DeVries JH; Bailey TS; Bhargava A; Gerety G; Gumprecht J; Heller S; Lane W; Wysham CH; Zinman B; Bak BA; Hachmann-Nielsen E; Philis-Tsimikas A
    Diabetes Obes Metab; 2019 Mar; 21(3):622-630. PubMed ID: 30362250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
    Svensson CH; Fabricius TW; Verhulst CEM; Kristensen PL; Tack CJ; Heller SR; Amiel SA; McCrimmon RJ; Evans M; Holst JJ; de Galan BE; Pedersen-Bjergaard U;
    Diabetes Obes Metab; 2024 Aug; 26(8):3213-3222. PubMed ID: 38774963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies.
    Pedersen-Bjergaard U; Alsifri S; Aronson R; Berković MC; Galstyan G; Gydesen H; Lekdorf JB; Ludvik B; Moberg E; Ramachandran A; Khunti K
    Diabetes Obes Metab; 2019 Apr; 21(4):844-853. PubMed ID: 30456887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
    Rosenstock J; Marre M; Qu Y; Zhang S; Bastyr EJ; Prince MJ; Chang AM
    Diabetes Obes Metab; 2016 Nov; 18(11):1093-1097. PubMed ID: 27484021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial.
    Bumbu A; Moutairou A; Matar O; Fumeron F; Velho G; Riveline JP; Gautier JF; Marre M; Roussel R; Potier L
    Diabetes Obes Metab; 2018 May; 20(5):1289-1292. PubMed ID: 29272063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypoglycaemia in patients with type 1 and type 2 diabetes mellitus on insulin therapy. Results of the global HAT study in Argentina].
    Costa Gil JE; Linari MA; Pugnaloni N; Zambon FG; Pérez Manghi F; Rezzónico M;
    Medicina (B Aires); 2017; 77(6):449-457. PubMed ID: 29223934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported non-severe hypoglycaemic events in Europe.
    Östenson CG; Geelhoed-Duijvestijn P; Lahtela J; Weitgasser R; Markert Jensen M; Pedersen-Bjergaard U
    Diabet Med; 2014 Jan; 31(1):92-101. PubMed ID: 23796113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.
    Lüddeke HJ; Sreenan S; Aczel S; Maxeiner S; Yenigun M; Kozlovski P; Gydesen H; Dornhorst A;
    Diabetes Obes Metab; 2007 May; 9(3):428-34. PubMed ID: 17391171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial.
    Renard E; Riveline JP; Hanaire H; Guerci B;
    Diabetes Obes Metab; 2022 May; 24(5):859-867. PubMed ID: 34984786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.
    Kulzer B; Seitz L; Kern W
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):167-72. PubMed ID: 24643694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from NPH insulin to once-daily insulin detemir in basal-bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE study.
    Sreenan S; Virkamäki A; Zhang K; Hansen JB;
    Int J Clin Pract; 2008 Dec; 62(12):1971-80. PubMed ID: 19166444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.